- Oil Major Total Profit Rises, Beats Consensus
- Euro Shares Fall 2%, Pharmas Lead Decline
- UK Recruiters Report Record Fall in Jobs
- European Stock Index Futures Give up Earlier Gains
- Chinese Officials Vow Help in Face of Slowing Growth
- Five Economic Challenges Ahead For Obama
- Demise of Australia's Allco a Sign of More to Come
- The New Investment World: Together and Separate
- JPMorgan to Close Prop Desk, Lay Off Traders: Source
- It's All Over But the T-Shirts
- And So It Goes ...
- Valliere: Can Obama Permanently Jump-start Confidence?
- At McCain Headquarters -- Johnny Cash!
- Time to Move to the Lawn
- Obama Appears and ... Nothing
- Lightning Round: Cisco, Morgan Stanley, Bristol-Myers and More
- Cramer's Outrage: The U.S. Treasury
- Cramer's Case for CAT
- Ahead of the Bell: Stocks after elections
- Ahead of the Bell: Activision to post 3Q results
- Hannover Re swings to 3Q loss of 395 million euros
- Ahead of the Bell: Government borrowing plans
- Ahead of the Bell: October service sector reading
- MillerCoors 3Q income rises 15 pct on cost savings
- Japan's Obama town celebrates namesake's victory
- Ciba 3Q profit down 8 pct, BASF deal advancing
- Asians uneasy over Obama trade stance
- Swisscom posts 32 percent drop in 3Q net profit
WOONSOCKET, R.I. - Drugstore operator CVS Caremark Corp. said Thursday it will debut a new savings program in which customers can get 90-day supplies of many generic drugs for $9.99.
The company said the Health Savings Pass program will cost $10, and members will be able to buy supplies of more than 400 common generic maintenance drugs for $9.99. A 10-percent discount at CVS MinuteClinics will also be included for clients who pay cash. The program will begin Nov. 9.
CVS Chief Executive Tom Ryan said the program will help consumers, particularly the uninsured and underinsured, during a difficult economic period. In the company's conference call he noted that many of CVS' rivals have similar savings programs.
CVS also reported its third-quarter results Thursday, and in morning trading, its shares rose $2.20, or 8.4 percent, to $28.51.

